
Krka, d. d.
Krka, d. d. is a Slovenia-based company in the Healthcare sector with a market capitalisation of $8.8B. Its FinScore is 63/100; its highest-scoring layer is Momentum (88) and its lowest is Value (36). The shares trade at 18.7x trailing earnings and are up 32% year to date.
Share price performance
About Krka, d. d.
www.krka.bizKrka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- Slovenia
- Fiscal year-end
- December
- Trading currency
- PLN
- Reporting currency
- EUR
- Fundamentals updated
- 87 days ago
- Market cap
- $8.8B
- Shares outstanding
- 30.3M
- P/E (TTM)
- 18.7x
- Dividend yield (TTM)
- 3.48%
- Beta (issuer)
- 0.46
- Revenue (latest FY)
- €2.0B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Krka, d. d. is available to Finryse members. The Overview stays open to everyone; creating an account is free.